Advanced Hepatocellular Carcinoma: Benefits of Atezolizumab and Bevacizumab in Clinical Practice. Case Report

Background: Hepatocellular carcinoma (HCC), originating from hepatocytes, ranks as the sixth most common cancer worldwide and the fourth leading cause of cancer-related mortality. Treatment options include surgical resection, locoregional therapies, systemic therapy, and liver transplantation, depe...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Erick Andrés Cantor Rizo, Andres Bejarano-Ramirez, Zamira Fernanda Gómez Giraldo, John Alejandro Murillo Silva, Henry Alexander Vargas Díaz, Mónica Lorena Tapias Mantilla
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Asociación Colombiana de Gastroenterología 2025-12-01
Serie:	Revista Colombiana de Gastroenterología
Soggetti:	Hepatocellular Carcinoma immunotherapy tyrosine kinase inhibitors
Accesso online:	https://www.revistagastrocol.com/index.php/rcg/article/view/1304
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!